Sandbox:Reddy: Difference between revisions
Blanked the page |
No edit summary |
||
Line 1: | Line 1: | ||
OUT Patient | |||
{| class="wikitable" | |||
|'''Dysenteric Diarrhea''' | |||
Frequent, sometimes bloody, small-volume diarrhea associated with abdominal pain and cramping. | |||
Patient may be febrile and toxic. | |||
|''Shigella'' | |||
''Salmonella'' | |||
''Campylobacter'' | |||
''Yersinia'' | |||
''E. coli'' 0157:H7 | |||
''''C.difficile'''' | |||
|'''Ciprofloxacin''' 500 mg PO BID | |||
OR | |||
'''Ciprofloxacin''' 750 mg daily x 3 days | |||
(avoid in cases of ''E. coli'' O157:H7 as it may increase the risk of hemolytic-uremic syndrome) | |||
Recent antibiotic exposure: consider ''C. difficile'' | |||
Antimotility drugs should not be used in ''C.difficile.'' | |||
''C. difficile -'' '''Metronidazole''' 500 mg PO TID x 10-14 days. If no response at 5 days, switch to '''Vancomycin''' 125mg PO QID x10-14 days. See inpatient guidelines for severe or recurrent ''C. difficile'' infection and/or policy on ''C. difficile'' management. | |||
| | |||
* '''Empiric therapy''' is generally indicated if patient is toxic appearing, elderly or immunocompromised. If empiric therapy is given, obtain culture and give fluoroquinolone x 3 days while awaiting cultures | |||
* '''Azithromycin''' should be used for pregnancy and suspected quinolone resistant ''Campylobacter.'' | |||
* Antimotility drugs improve symptoms and can be used if patient is not toxic. | |||
* Antimicrobial treatment may worsen outcomes in patients with ''E. coli''0157:H7 | |||
* ''E. histolytica'' - '''Metronidazole''' 750 mg PO TID x 7-10 days then '''Iodoquinol''' 650 mg PO TID x 20 days or '''Paromomycin'''5 25-35 mg/kg/day in 3 divided doses x 7 days | |||
|- | |||
|'''Nondysenteric Diarrhea''' | |||
Large volume, nonbloody, watery diarrhea. | |||
Patient may have nausea, vomiting, and abdominal cramping but fever often absent. | |||
|Viruses | |||
''Giardia'' | |||
Enterotoxigenic ''E. coli'' | |||
''Enterotoxin-producing bacteria'' | |||
|General Care: Observation | |||
Oral rehydration | |||
Antimotility agents | |||
''Giardia –'' especially if patient describes recent history of travel and/or ingestion of unfiltered water (e.g., camping), consider – '''Metronidazole''' 250 mg PO TID x 5 days. | |||
| | |||
* Generally, empiric therapy and stool cultures are '''not''' indicated. Most disease is self-limiting and can be treated with antimotility agents | |||
* If patient fails to improve, cultures (-), and symptoms persist, consider stool for O & P. | |||
* Metronidazole resistance seen in 20% giardia cases. Check ''C. difficile'' toxin if recent history of antibiotic use or hospitalization. | |||
|- | |||
|'''Traveler’s diarrhea''' | |||
Empiric treatment while abroad | |||
|Toxigenic ''E. coli'' | |||
''Salmonella'' | |||
''Shigella'' | |||
''Campylobacter'' | |||
Amebiasis | |||
|'''Ciprofloxacin''' 500 mg PO BID x 1-3 days | |||
Pregnancy or fluoroquinolone-resistant campylobacter: | |||
'''Azithromycin''' 1 g x 1 dose | |||
EITHER WITH or WITHOUT: | |||
'''Loperamide''' 4 mg PO x 1; then 2 mg after each loose stool, | |||
MAX 16 mg/day | |||
|Mild, self-limited cases can be treated with fluid and electrolyte repletion and bismuth subsalicylate. | |||
Prophylaxis generally not recommended. | |||
|} |
Revision as of 19:50, 29 June 2017
OUT Patient
Dysenteric Diarrhea
Frequent, sometimes bloody, small-volume diarrhea associated with abdominal pain and cramping. Patient may be febrile and toxic. |
Shigella
Salmonella Campylobacter Yersinia E. coli 0157:H7 'C.difficile' |
Ciprofloxacin 500 mg PO BID
OR Ciprofloxacin 750 mg daily x 3 days (avoid in cases of E. coli O157:H7 as it may increase the risk of hemolytic-uremic syndrome) Recent antibiotic exposure: consider C. difficile Antimotility drugs should not be used in C.difficile. C. difficile - Metronidazole 500 mg PO TID x 10-14 days. If no response at 5 days, switch to Vancomycin 125mg PO QID x10-14 days. See inpatient guidelines for severe or recurrent C. difficile infection and/or policy on C. difficile management. |
|
Nondysenteric Diarrhea
Large volume, nonbloody, watery diarrhea. Patient may have nausea, vomiting, and abdominal cramping but fever often absent. |
Viruses
Giardia Enterotoxigenic E. coli Enterotoxin-producing bacteria |
General Care: Observation
Oral rehydration Antimotility agents Giardia – especially if patient describes recent history of travel and/or ingestion of unfiltered water (e.g., camping), consider – Metronidazole 250 mg PO TID x 5 days. |
|
Traveler’s diarrhea
Empiric treatment while abroad |
Toxigenic E. coli
Salmonella Shigella Campylobacter Amebiasis |
Ciprofloxacin 500 mg PO BID x 1-3 days
Pregnancy or fluoroquinolone-resistant campylobacter: Azithromycin 1 g x 1 dose EITHER WITH or WITHOUT: Loperamide 4 mg PO x 1; then 2 mg after each loose stool, MAX 16 mg/day |
Mild, self-limited cases can be treated with fluid and electrolyte repletion and bismuth subsalicylate.
Prophylaxis generally not recommended. |